Thrombosis
Feature
Novel drug targets raised Lp(a): topline results released
Significant reductions in lipoprotein(a) were sustained out to 150 days in patients without cardiovascular disease in top-line phase 1 results...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
Ischemic stroke rates higher in young women than young men
Young women may be at a higher risk of ischemic stroke than young men, representing a “significant departure from our current scientific...
Feature
CVS Caremark formulary change freezes out apixaban
The decision doesn’t affect patients on a Medicare or Medicaid plan but hits those taking the popular anticoagulant who have select commercial...
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
Guidelines
ACC, AHA issue new coronary revascularization guideline
The clinical practice guideline calls for greater equity in patient care and tackles the timely issues of revascularization in stable ischemic...
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
Conference Coverage
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
Latest News
Exercise reduces arm and shoulder problems after breast cancer surgery
Study provides the best quality evidence to date in support of early exercise for women at high risk of shoulder problems after breast cancer...
Conference Coverage
PRAGUE-17: LAA closure holds up against DOACs out to 4 years
Most outcomes remained unchanged, but follow-up imaging curtailed by the COVID-19 pandemic leaves an unfortunate gap with regard to late device-...